Data from clinical trials suggest the Pfizer/BioNTech Covid-19 vaccine is safe and likely effective in people who were previously infected with the coronavirus, and vaccination should be offered to them, the US Centers for Disease Control and Prevention’s Advisory Community on Immunization Practices was told during a meeting on Saturday.

Diagnostic or antibody testing is not recommended for vaccine decision-making, CDC’s Dr. Sarah Mbaeyi said during a presentation to the committee.

However, people with a current infection should not be vaccinated until a person has recovered, if they had symptoms, and if they’re clear to leave isolation. There’s no recommended minimum period between infection and vaccination, but since it appears reinfection is uncommon in the 90 days after initial infection, vaccination could be delayed until near the end of that period.

People who have a known Covid-19 exposure shouldn’t seek vaccination …continued .
[Original Source: CNN]